Health Condition 1: H958- Other intraoperative and postprocedural complications and disorders of the ear and mastoid process, not elsewhere classified
Conditions
Interventions
Intervention1: Dexmedetomidine: Dexmedetomidine 1 microgram/kg body weight diluted in 100 ml of 0.9% normal saline intravenous is administered over 10 minutes as the loading dose. For infusion 100mcg
Sponsors
Shri BM Patil Medical College
Eligibility
Inclusion criteria
Inclusion criteria: ASA grade 1 and 2
Exclusion criteria
Exclusion criteria: Denial to participate Hypersensitivity to the drugs studied Long term opioid use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| comparison of the time taken for reaching the target MAP in the two study drugs. group A is given inj Magnesiusm sulphate i/v loading dose 40 mg/kg diluted in 100 ml 0.9% normal saline over a period of 10 mins followed by an iv infusion of 10-15 mg/kg/hr via an infusion pump. group B is given inj Dexmeditomidine iv loading dose of 1mcg/kr diluted in 100 ml 0.9% normal saline over 10 mins followed by an iv infusio n at 0.2-0.7 mcg/kg/hr via an infusion pump.Timepoint: comparison of the time taken for reaching the target MAP in the two study drugs. baseline readings are noted down and later at the time of induction, intubation, at the time of drug administration, 5 mins, 10 mins and 15 mins after drug administration. | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare the number of patients requiring a minimum and maximun infusion doses of study drugs.Timepoint: 1.5 yrs | — |
Countries
India
Contacts
Public ContactNayantara K P
Shri B M Patil Medical College
Outcome results
None listed